| Financial Year |
March 31 2023 |
| Monetary Funds |
2,346,670,578.19 |
| Held-for-trading Financial Assets |
2,418,624,990.70 |
| Notes Receivable |
11,638,336.05 |
| Accounts Receivable |
1,283,961,513.11 |
| Advances to Suppliers |
20,443,491.43 |
| Other Receivables |
15,512,881.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,869,983.95 |
| Inventories |
30,683,779.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,898,346.35 |
| Total Current Assets |
6,190,392,720.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
235,810,331.24 |
| Investment Properties |
291,670,056.04 |
| Fixed Assetes |
1,014,896,035.30 |
| Under-construction Projects |
32,824,824.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,760,496.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
113,802,773.77 |
| Deferred Income Tax Assets |
60,144,652.42 |
| Other Non-Current Assets |
2,129,232,734.45 |
| Sub-Total of Non-Current Assets |
4,361,599,129.95 |
| Total Assets |
10,551,991,850.13 |
| Short-Term Loans |
144,503,611.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
738,804,425.72 |
| Accounts Received In Advance |
1,024,000.00 |
| Employee Compensation Payable |
105,269,563.50 |
| Taxes Payable |
99,327,838.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
67,978,433.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,422,512.55 |
| Other Current Liabilities |
5,088,311.11 |
| Sub-Total of Current Liabilities |
1,281,661,156.68 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
637,873.23 |
| Deferred Income Tax Liabilities |
3,208,981.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
80,240,395.49 |
| Total Liabilities |
1,361,901,552.17 |
| Paid-In Capital(Or Share Stock) |
2,437,230,675.00 |
| Capital Surplus |
2,342,444,902.75 |
| Surplus Reserve |
596,984,227.39 |
| LESS:Treasury Stock |
127,350,218.30 |
| Undistributed Profits |
3,946,465,125.10 |
| Minority Stockholder's Interest |
51,762,658.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,138,327,639.68 |
| Owner's Equity（Stockholder's Equity） |
9,190,090,297.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,551,991,850.13 |
